《大行報告》麥格理下調新地(00016.HK)目標價至159.17元 評級「跑贏大市」
麥格理發表報告指,新鴻基地產(00016.HK)管理層維持審慎銷售目標,2020年度目標為400億元,該行相信新地會超標35%,錄高達540億元,2021年度更達570億元。
不過該行下調新地將於短期內推售項目的平均價格5%至10%,以反映本地及宏觀經濟放緩且市場情緒波動的因素。同時分別下降2020至2021年度的每股盈利預測7.2%及3.5%,目標價相應由172.06元降至159.17元,維持「跑贏大市」評級。
報告補充,新地股價於過去十二個月基本上持平,現價估值吸引,惟相信明年第一季才是入市良機,屆時整體地產及零售氣氛有望改善。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.